The World Health Organization (WHO) warned on Monday about the increased consumption of antibiotics in some countries, as well as low consumption in other regions, which could lead to the death of a "superbacterial".
The WHO report, based on data for 2015 in 65 countries and regions, shows a significant difference in consumption from four specific daily doses (DDD) to 1,000 people per day in Burundi to over 64 Mongolia.
"These differences suggest that some countries are likely to use too much antibiotics, while other countries may not have enough access to the drug," the WHO statement said.
In the 1920s, antibiotics have saved tens of millions of lives that effectively fight bacteriological diseases such as pneumonia, tuberculosis and meningitis.
However, over the years bacteria have been modified to resist this medicine.
WHO has repeatedly warned that the number of effective antibiotics in the world is deteriorating.
Last year, the UN agency specifically asked nations and large pharmaceutical groups to create a new generation of medicines that could fight against particularly resistant "superbacteria".
"Over-consumption, as well as insufficient consumption of antibiotics, are the main causes of resistance to antimicrobials," said Suzanne Hill, Director of the World Health Organization (WHO) Drug and Important Health Products.
"We will lose the ability to treat infections"
"Without effective antibiotics and other antimicrobials, we will lose the ability to treat infections as widely as pneumonia," he said.
Bacteria may become resistant if patients are taking antibiotics that are not needed or if they do not complete the treatment. Thus, bacteria have more opportunities to survive and develop immunity.
But WHO is also worried about the low consumption of antibiotics.
"Endurance can develop when patients can not afford full treatment or just access to lower quality or changeable medicines," says the report.
In Europe, the average consumption of antibiotics is about 18 DDD per 1,000 inhabitants per day. Turkey runs the list (38 DDDs), which is about 5 times more than the last one, Azerbaijan (8 DDDs).
However, the WHO recognizes that its report is incomplete, since it only includes four African countries, three countries in the Middle East and six countries in the Asia-Pacific region. Moreover, the great reservations of this study are the United States, China and India.
Since 2016, the WHO has helped 57 low and middle income countries collect data to establish a standardized system for tracking antibiotics.